Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-ONC-12002682Phase 4Completed
Phase 4, open-label trial of alfentanil (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Alfentanil plasma concentration and Pharmacokinetic parameters. Started Jun 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-ONC-12002682.